24/03/2023
UNITE4TB explored how low- and middle-income countries can roll out the molecular diagnostic tests needed to determine the best course of treatment for people diagnosed with TB.
UNITE4TB explored how low- and middle-income countries can roll out the molecular diagnostic tests needed to determine the best course of treatment for people diagnosed with TB.
The AMR Accelerator is a proven model for the development of new antimicrobial drugs, experts say